A Delaware District Court ruled in favor of AstraZeneca for cholesterol blockbuster patent protection, Crestor (Rosuvastatin) drug, after nine generic drug manufacturers challenged AstraZeneca's patent. The economic version will not be able to be marketed until late 2016.

According to a German court, GlaxoSmithKline Plc. patents of Advair (Fluticasone + Salmeterol), are not valid, and setting the asthma and chronic obstructive pulmonary disease drug at risk in the main European market.

Merck & Co. announced that a N.Y. federal court ruled in favor over a lawsuit filed by a 69 years old women, that alleged teeth and jawbones deterioration dut to a treatment with osteoporosis drug, Fosamax.

U.S. Generics company Watson Pharmaceuticals Inc. announced that an appeals court ruled in favor of attention defficit drug Concentra (Methylphenidate) for patent dispute with Johnson & Johnson Inc.

The U.S. appeals court gave a positive ruling that will help Bristol-Myers and Sanofi-Aventis avoid generic competition to the blood-thinner Plavix (clopidrogel), one of the world’s best selling drugs, until 2011.

Barr Pharmaceuticals announced that the U.S. Court of Appeals for the Federal Circuit has upheld the 2005 decision of the U.S. District Court for the Eastern District of New York, which rejected a challenge to the lawfulness of a 1997 patent litigation settlement, between Barr Laboratories and Bayer AG related to the antibiotic Cipro

Eli Lilly & Co. announced it will pay $ 62 million dollars to resolve investigations into the marketing and promotion of its antipsychotic drug Zyprexa in 32 states and Washington, D.C.

A U.S. court affirmed a jury verdict upholding Amgen Inc patents on its blockbuster anemia drugs Aranesp and Epogen, effectively blocking Roche Holding AG from marketing its Mircera in the U.S.

AstraZeneca Plc said that the U.S. District Court for the District of New Jersey has denied Teva Pharmaceutical Industries´ motion for summary judgment of no infringement of patent litigation for AstraZeneca´s asthma treatment Pulmicort Respules (Budesonide). Further details.

Israel-based Teva Pharmaceutical Industries Ltd., the world's largest generics drugmaker, said that following a hearing on September 12, 2008, the U.S. Court of Appeals (District of Columbia) has vacated an April 2008 ruling, which granted the company 180-day exclusivity for its Risperidone Tablets, an antipsychotic drug.

A U.S. federal appeals court has reinstated a securities fraud lawsuit against Merck & Co Inc related to disclosures to investors involving its withdrawn Vioxx pain drug. Merck may renew its request to dismiss the suit on alternative grounds.

A U.S. judge has emitted a ruling on lawsuits involving Eli Lilly & Co´s anti-psychotic drug Zyprexa, stating that pension funds, labor unions and insurance companies can sue the company as a group in a class action suit. The amount of the individual $ 7.7 billion dollars claim for overpricing has been lowered to $ 6.8 billion dollars. Further details.

Pfizer Inc. announced a Danish court in Denmark has blocked Ranbaxy Laboratories from launching a generic version of the giant U.S. drugmaker´s blockbuster cholesterol drug Lipitor in that country.

In a motion favoring Bristol-Myers Squibb shareholders, a U.S. judge has ruled that the company misled two pension funds regarding information about its patent litigation settlement with Canadian generic drug maker Apotex Inc over the blood-thinner Plavix. No amount has been disclosed. Further details.

A judge approved Abbott Laboratories pay a settlement for up to $ 27.5 million dollars to cover claims for overcharging patients in sales of HIV treatment Norvir. Plaintiffs´ claims are worth as much as $ 1.1 billion dollars. Further details.